We have previously demonstrated that survivin, the number 4 transcript up-regulated in cancer [30], is a Wnt/CBP/β-catenin target in colorectal cancer cells and colorectal cancer patient circulating tumor cells [25,31] and its expression is decreased upon treatment with specific CBP/β-catenin antagonists. Here, BIRC5 is linked to neoplasm.